AIThis post was created with the assistance of artificial intelligence (AI).

TL;DR

For listenersOffer from Amazon

Turn your wind-down time into listening time

  • Thousands of audiobooks, podcasts and originals
  • Listen on your phone, tablet or Echo — also offline
  • Cancel anytime
Try Audible free Free trial for new members
As an affiliate, we earn on qualifying purchases.

In a MedPage Today video published Oct. 19, Michael Osterholm argued that credible vaccine-safety research depends on study plans set before researchers examine results, open methods and data, reproducible analyses, and expert scrutiny. He also questioned whether some proposed studies would add useful information beyond existing vaccine-safety monitoring; the report does not identify those studies or independently assess that claim.

Michael Osterholm, executive director of the Vaccine Integrity Project, said vaccine-safety research is most credible when its questions, methods and outcome definitions are set before researchers analyze data, and when others can review and reproduce the work. In a video published by MedPage Today on October 19, he argued that those practices matter to scientific reliability and public trust as debate continues over vaccine safety.

Osterholm said researchers should explain what information gap a study is intended to address and distinguish that purpose from testing a prior belief about vaccines. He argued that the desire for more safety information does not replace the need for scientifically sound study design.

He highlighted decisions that should be made in advance: how researchers define vaccinated and comparison groups, which health outcomes they measure, and how they determine what happened to a patient after a possible adverse reaction. Predetermining those choices, he said, can reduce the risk of selecting figures after the fact to support a preferred conclusion.

Osterholm also described making data and analytical tools available so outside researchers and the public can repeat an analysis or document differences. He said findings should then receive expert review, including scrutiny of whether an observed association suggests a cause or could have appeared by chance after many analyses.

At a glance
reportWhen: Published October 19, 2026
The developmentMichael Osterholm has set out standards for credible vaccine-safety studies in a MedPage Today video, stressing transparency and reproducibility.

Study Design Shapes Public Trust

Vaccine-safety findings can affect health decisions and confidence in public health. Transparent methods let readers and other researchers see how a study reached its conclusions, while reproducibility offers a way to check whether the results follow from the data and analytical choices.

Osterholm’s comments also address how research is presented before results are known. If a study’s methods or definitions are contested, raising those concerns while the work is underway may help audiences judge later claims with more information. That is his argument; the video does not establish that any particular study is flawed or that transparency alone resolves disputes about vaccine safety.

Amazon

vaccine safety research analysis tools

As an affiliate, we earn on qualifying purchases.

As an affiliate, we earn on qualifying purchases.

Osterholm’s Case for Prespecified Methods

The MedPage Today report presents Osterholm’s remarks in its “Off the ‘Page” video series and describes them as reflecting a recent viewpoint. The material provided does not give the viewpoint’s publication date or identify specific proposed studies that prompted his comments.

Osterholm said he did not see benefits from the kinds of studies being proposed that were not already addressed by the existing rigorous safety overview of current vaccines. That is his assessment, not an independently demonstrated finding in the video transcript. The report does not supply a comparison of particular studies, safety-monitoring systems or their results.

“The most important word that one can think about in talking about these kinds of studies is ‘transparency.'”

— Michael Osterholm, executive director of the Vaccine Integrity Project

Amazon

transparent data analysis software

As an affiliate, we earn on qualifying purchases.

As an affiliate, we earn on qualifying purchases.

Studies and Evidence Still Unspecified

The report does not name the proposed studies Osterholm criticizes, detail their protocols, or provide evidence with which to evaluate his view that they would add no benefit. It also does not describe the existing safety-monitoring systems he references or compare their coverage with the questions those studies might address.

No new vaccine-safety results are presented in the video material. The comments set out standards and concerns, rather than reporting a study’s findings. Whether any specific research meets those standards, and what its results show, remains unclear from the source.

Amazon

reproducible research software

As an affiliate, we earn on qualifying purchases.

As an affiliate, we earn on qualifying purchases.

Watch for Protocols and Reviews

The next useful developments would be publication of study protocols, clear explanations of outcome and comparison-group definitions, and access to data and analysis methods where appropriate. Those details would allow independent researchers to examine whether the design was set in advance and whether results can be reproduced.

Expert review of any findings will also matter, particularly when studies test many possible outcomes. The MedPage Today report does not give a timetable for proposed studies, identify a forthcoming review, or state when additional information will be released.

Amazon

medical study review tools

As an affiliate, we earn on qualifying purchases.

As an affiliate, we earn on qualifying purchases.

Key Questions

What does Osterholm say makes vaccine-safety research credible?

He points to a clearly stated research question, study decisions made before data analysis, transparent methods and data, reproducible analyses, and expert review.

Why should study methods be set in advance?

Osterholm says defining groups and outcomes beforehand can reduce the risk of choosing analyses or figures after results are visible in ways that support a preferred conclusion.

Does an association prove a vaccine caused an outcome?

No. Osterholm cautions that an association can arise by chance, especially when researchers run many analyses. A finding needs further assessment before it is treated as evidence of cause and effect.

Did the report identify a specific flawed vaccine study?

No. The report conveys Osterholm’s concerns about proposed studies but does not name them or provide their protocols or results.

What information is still needed?

Details about the studies in question, their prespecified methods, data access, and independent reviews would help readers assess whether they add evidence and how reliable their findings are.

Source: rss

This article is for informational purposes only and is not medical advice. Always consult a qualified healthcare professional about your specific situation.
FALL

Fall Picks

As an affiliate, we earn on qualifying purchases.

You May Also Like

Pete Hegseth Says Soldiers Over Age 30 To Be Screened For Testosterone Deficiency

Pete Hegseth suggests soldiers over age 30 be screened for testosterone deficiency, raising questions about military health policies and implications.

What’s Next For Chronic Hives? New Targets Expand The Treatment Landscape.

AAD meeting coverage highlighted BTK, IL-4 receptor and c-KIT approaches for chronic hives, including emerging data in inducible urticaria.

Restaurant

Health officials confirm a local restaurant in North Alabama is linked to a cyclospora outbreak affecting dozens of customers, prompting investigation and warnings.

Even In Those Days, Chennai’s Medical Facilities Were On Par With Rest Of The Country – Thehindu.com

Historical analysis confirms Chennai’s medical facilities matched national standards, even in earlier decades, highlighting its longstanding healthcare reputation.